IL6 and plasma cell myeloma: Specially, other groups demonstrate the inhibition of ERK without interference with phosphorylation of STAT3 [12], as well as the inhibition of arsenic trioxide on IL-6-induced STAT3 but not ERK activation in myeloma cells [59].